Pharma Mar S.A. (PHM) — Cash Flow-to-Debt Ratio
Pharma Mar S.A. (PHM) has a Cash Flow-to-Debt Ratio of 0.23x as of December 2025, meaning its operating cash flow of €33.58 Million could theoretically repay 0% of its total liabilities (€143.25 Million) in one year. See PHM financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharma Mar S.A. Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Pharma Mar S.A. across 23 annual periods. For the full cash flow conversion analysis, see how efficiently does Pharma Mar S.A. generate cash.
Annual Cash Flow-to-Debt Ratio for Pharma Mar S.A. (2002–2025)
Year-by-year debt coverage analysis for Pharma Mar S.A.. Check Pharma Mar S.A. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.37x | €53.13 Million | €143.25 Million | ▲ +769.5% |
| 2024 | 0.04x | €6.03 Million | €141.28 Million | ▲ +146.7% |
| 2023 | -0.09x | €-13.45 Million | €147.08 Million | ▼ -140.6% |
| 2022 | 0.23x | €38.32 Million | €170.30 Million | ▲ +66.9% |
| 2021 | 0.13x | €25.68 Million | €190.47 Million | ▼ -89.0% |
| 2020 | 1.23x | €278.94 Million | €227.54 Million | ▲ +649.9% |
| 2019 | -0.22x | €-26.14 Million | €117.25 Million | ▼ -91.3% |
| 2018 | -0.12x | €-16.34 Million | €140.20 Million | ▼ -1215.9% |
| 2017 | -0.01x | €-1.46 Million | €164.74 Million | ▲ +81.8% |
| 2016 | -0.05x | €-8.41 Million | €172.64 Million | ▼ -161.0% |
| 2015 | 0.08x | €11.10 Million | €138.90 Million | ▼ -48.9% |
| 2014 | 0.16x | €22.11 Million | €141.32 Million | ▲ +33.9% |
| 2013 | 0.12x | €16.34 Million | €139.94 Million | ▲ +197.8% |
| 2012 | 0.04x | €6.32 Million | €161.10 Million | ▲ +267.9% |
| 2011 | -0.02x | €-4.28 Million | €183.31 Million | ▲ +79.1% |
| 2010 | -0.11x | €-21.90 Million | €195.96 Million | ▲ +16.1% |
| 2009 | -0.13x | €-22.67 Million | €170.18 Million | ▲ +40.9% |
| 2008 | -0.23x | €-35.66 Million | €158.20 Million | ▲ +38.8% |
| 2007 | -0.37x | €-49.16 Million | €133.51 Million | ▲ +23.1% |
| 2006 | -0.48x | €-56.11 Million | €117.23 Million | ▲ +51.2% |
| 2005 | -0.98x | €-33.03 Million | €33.68 Million | ▼ -98.9% |
| 2003 | -0.49x | €-67.18 Million | €136.20 Million | ▼ -44.6% |
| 2002 | -0.34x | €-35.64 Million | €104.53 Million | — |